Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3P1E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,650
Award facts
- Contract value 100% obligated
- $32,650.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $32,650.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a competitive award with no set-aside designation, with an ultimate completion date of December 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical supply vehicle valued through December 2026 that enables the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare operations. The company has demonstrated consistent capability to meet federal procurement requirements through open competition, with an extensive portfolio of delivery orders covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and other specialized medical commodities. The DLA Troop Support Medical contract vehicle under which this award is issued represents a flexible and comprehensive mechanism for supplying medications and medical supplies across multiple therapeutic domains to support the Department of Defense healthcare mission globally.
Quick answers
Who was awarded contract SPE2DR26F3P1E?
SPE2DR26F3P1E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F3P1E worth?
The government has obligated $32,650 on SPE2DR26F3P1E.
Is contract SPE2DR26F3P1E an order under another contract?
Yes. SPE2DR26F3P1E is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P1E competed?
The extent of competition for SPE2DR26F3P1E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award